-
1
-
-
55249092701
-
Genomics research: World survey of public funding
-
Pohlhaus JR, Cook-Deegan RM (2008) Genomics research: world survey of public funding. BMC Genomics 9:472
-
(2008)
BMC Genomics
, vol.9
, pp. 472
-
-
Pohlhaus, J.R.1
Cook-Deegan, R.M.2
-
2
-
-
67649732906
-
Challenges of translating genetic tests into clinical and public health practice
-
Rogowski WH, Grosse SD, Khoury MJ (2009) Challenges of translating genetic tests into clinical and public health practice. Nat Rev Genet 10:489-495
-
(2009)
Nat Rev Genet
, vol.10
, pp. 489-495
-
-
Rogowski, W.H.1
Grosse, S.D.2
Khoury, M.J.3
-
3
-
-
26444505936
-
Translational and clinical science - Time for a new vision
-
DOI 10.1056/NEJMsb053723
-
Zerhouni EA (2005) Translational and clinical science-time for a new vision. N Engl J Med 353:1621-1623 (Pubitemid 41434645)
-
(2005)
New England Journal of Medicine
, vol.353
, Issue.15
, pp. 1621-1623
-
-
Zerhouni, E.A.1
-
4
-
-
37349116252
-
The continuum of translation research in genomic medicine: How can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention?
-
DOI 10.1097/GIM.0b013e31815699d0, PII 0012581720071000000001
-
Khoury MJ, Gwinn M, Yoon PW et al (2007) The continuum of translation research in genomic medicine: How can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? Genet Med 9:665-674 (Pubitemid 350287151)
-
(2007)
Genetics in Medicine
, vol.9
, Issue.10
, pp. 665-674
-
-
Khoury, M.J.1
Gwinn, M.2
Yoon, P.W.3
Dowling, N.4
Moore, C.A.5
Bradley, L.6
-
5
-
-
70649084197
-
Entscheidungsanalytische Modellierung von Kosten pro QALY im Kontext des deutschen Sozialrechts
-
Rogowski WH, Landauer M, John J (2009) Entscheidungsanalytische Modellierung von Kosten pro QALY im Kontext des deutschen Sozialrechts. Gesundheitswesen 71:739-750
-
(2009)
Gesundheitswesen
, vol.71
, pp. 739-750
-
-
Rogowski, W.H.1
Landauer, M.2
John, J.3
-
6
-
-
44649149706
-
Does health care spending improve health outcomes? Evidence from English programme budgeting data
-
Martin S, Rice N, Smith PC (2008) Does health care spending improve health outcomes? Evidence from English programme budgeting data. J Health Econ 27:826-842
-
(2008)
J Health Econ
, vol.27
, pp. 826-842
-
-
Martin, S.1
Rice, N.2
Smith, P.C.3
-
7
-
-
0033044884
-
The irrelevance of inference: A decision-making approach to the stochastic evaluation of health care technologies
-
DOI 10.1016/S0167-6296(98)00039-3, PII S0167629698000393
-
Claxton K (1999) The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. J Health Econ 18:341-364 (Pubitemid 29242816)
-
(1999)
Journal of Health Economics
, vol.18
, Issue.3
, pp. 341-364
-
-
Claxton, K.1
-
8
-
-
33750600068
-
Using value of information analysis to prioritise health research: Some lessons from recent UK experience
-
Claxton KP, Sculpher MJ (2006) Using value of information analysis to prioritise health research: some lessons from recent UK experience. Pharmaco Econ 24:1055-1068 (Pubitemid 44683363)
-
(2006)
PharmacoEconomics
, vol.24
, Issue.11
, pp. 1055-1068
-
-
Claxton, K.P.1
Sculpher, M.J.2
-
9
-
-
33845662699
-
Informing the efficient use of health care and health care research resources - The case of screening for abdominal aortic aneurysm in Sweden
-
DOI 10.1002/hec.1130
-
Henriksson M, Lundgren F, Carlsson P (2006) Informing the efficient use of health care and health care research resources - the case of screening for abdominal aortic aneurysm in Sweden. Health Econ 15:1311-1322 (Pubitemid 44941607)
-
(2006)
Health Economics
, vol.15
, Issue.12
, pp. 1311-1322
-
-
Henriksson, M.1
Lundgren, F.2
Carlsson, P.3
-
10
-
-
4444284468
-
A pilot study on the use of decision theory and value of information analysis as part of the NHS Health Technology Assessment programme
-
iii
-
Claxton K, Ginnelly L, Sculpher M et al (2004) A pilot study on the use of decision theory and value of information analysis as part of the NHS Health Technology Assessment programme. Health Technol Assess 8:1-103, iii
-
(2004)
Health Technol Assess
, vol.8
, pp. 1-103
-
-
Claxton, K.1
Ginnelly, L.2
Sculpher, M.3
-
12
-
-
64549148979
-
The cost-effectiveness of screening for hereditary hemochromatosis in Germany: A remodeling study
-
Rogowski WH (2009) The cost-effectiveness of screening for hereditary hemochromatosis in Germany: a remodeling study. Med Decis Making 29:224-238
-
(2009)
Med Decis Making
, vol.29
, pp. 224-238
-
-
Rogowski, W.H.1
-
13
-
-
33746830877
-
Screening for hereditary hemochromatosis: A systematic review for the U.S. preventive services task force
-
Whitlock EP, Garlitz BA, Harris EL et al (2006) Screening for hereditary hemochromatosis: a systematic review for the U. S. preventive services task force. Ann Intern Med 145:209-223 (Pubitemid 46780566)
-
(2006)
Annals of Internal Medicine
, vol.145
, Issue.3
, pp. 209-223
-
-
Whitlock, E.P.1
Garlitz, B.A.2
Harris, E.L.3
Beil, T.L.4
Smith, P.R.5
-
14
-
-
25444500981
-
Screening primary care patients for hereditary hemochromatosis with transferrin saturation and serum ferritin level: Systematic review for the American College of Physicians
-
Schmitt B, Golub RM, Green R (2005) Screening primary care patients for hereditary hemochromatosis with transferrin saturation and serum ferritin level: systematic review for the American College of Physicians. Ann Intern Med 143:522-536
-
(2005)
Ann Intern Med
, vol.143
, pp. 522-536
-
-
Schmitt, B.1
Golub, R.M.2
Green, R.3
-
15
-
-
72849151855
-
Population screening for genetic disorders in the 21st century: Evidence, economics, and ethics
-
Grosse SD, Rogowski WH, Ross LF et al (2010) Population screening for genetic disorders in the 21st century: evidence, economics, and ethics. Public Health Genomics 13:106-115
-
(2010)
Public Health Genomics
, vol.13
, pp. 106-115
-
-
Grosse, S.D.1
Rogowski, W.H.2
Ross, L.F.3
-
16
-
-
36549053552
-
Haemochromatosis
-
DOI 10.1016/S0140-6736(07)61782-6, PII S0140673607617826
-
Adams PC, Barton JC (2007) Haemochromatosis. Lancet 370:1855-1860 (Pubitemid 350180034)
-
(2007)
Lancet
, vol.370
, Issue.9602
, pp. 1855-1860
-
-
Adams, P.C.1
Barton, J.C.2
-
17
-
-
33845545966
-
Hereditary hemochromatosis screening: Effect of mutation penetrance and prevalence on cost-effectiveness of testing algorithms
-
DOI 10.1111/j.1399-0004.2006.00727.x
-
Gagne G, Reinharz D, Laflamme N et al (2007) Hereditary hemochromatosis screening: effect of mutation penetrance and prevalence on costeffectiveness of testing algorithms. Clin Genet 71:46-58 (Pubitemid 44921621)
-
(2007)
Clinical Genetics
, vol.71
, Issue.1
, pp. 46-58
-
-
Gagne, G.1
Reinharz, D.2
Laflamme, N.3
Adams, P.C.4
Rousseau, F.5
-
18
-
-
33750583986
-
Leitlinie zur molekulargenetischen Diagnostikder hereditären Hämochromatose
-
Gabriel H, Stuhrmann M (2006) Leitlinie zur molekulargenetischen Diagnostikder hereditären Hämochromatose. Med Genet 18:273-278
-
(2006)
Med Genet
, vol.18
, pp. 273-278
-
-
Gabriel, H.1
Stuhrmann, M.2
-
19
-
-
12744260147
-
Genotype-based screening for hereditary haemochromatosis. I: Technical performance, costs and clinical relevance of a German pilot study
-
Stuhrmann M, Strassburg C, Schmidtke J (2005) Genotype-based screening for hereditary haemochromatosis. I: technical performance, costs and clinical relevance of a German pilot study. Eur J Hum Genet 13:69-78
-
(2005)
Eur J Hum Genet
, vol.13
, pp. 69-78
-
-
Stuhrmann, M.1
Strassburg, C.2
Schmidtke, J.3
-
20
-
-
0036793757
-
Benefit of population-based screening for phenotypic hemochromatosis in young men
-
DOI 10.1080/003655202760373443
-
Asberg A, Tretli S, Hveem K, Bjerve KS (2002) Benefit of population-based screening for phenotypic hemochromatosis in young men. Scand J Gastroenterol 37:1212-1219 (Pubitemid 35178688)
-
(2002)
Scandinavian Journal of Gastroenterology
, vol.37
, Issue.10
, pp. 1212-1219
-
-
Asberg, A.1
Tretli, S.2
Hveem, K.3
Bjerve, K.S.4
-
21
-
-
84942476530
-
Cost-effectiveness of screening for hereditary hemochromatosis
-
DOI 10.1001/archinte.154.7.769
-
Phatak PD, Guzman G, Woll JE et al (1994) Cost-effectiveness of screening for hereditary hemochromatosis. Arch Intern Med 154:769-776 (Pubitemid 24115664)
-
(1994)
Archives of Internal Medicine
, vol.154
, Issue.7
, pp. 769-776
-
-
Phatak, P.D.1
Guzman, G.2
Woll, J.E.3
Robeson, A.4
Phelps, C.E.5
-
22
-
-
1442282237
-
Evolution of Untreated Hereditary Hemochromatosis in the Busselton Population: A 17-Year Study
-
Olynyk JK, Hagan SE, Cullen DJ et al (2004) Evolution of untreated hereditary hemochromatosis in the Busselton population: a 17-year study. Mayo Clin Proc 79:309-313 (Pubitemid 38269232)
-
(2004)
Mayo Clinic Proceedings
, vol.79
, Issue.3
, pp. 309-313
-
-
Olynyk, J.K.1
Hagan, S.E.2
Cullen, D.J.3
Beilby, J.4
Whittall, D.E.5
-
23
-
-
2442715056
-
Implementation of HaemScreen, a workplace-based genetic screening program for hemochromatosis
-
DOI 10.1111/j.1399-0004.2004.0239.x
-
Nisselle AE, Delatycki MB, Collins V et al (2004) Implementation of HaemScreen, a workplace-based genetic screening program for hemochromatosis. Clin Genet 65:358-367 (Pubitemid 38659704)
-
(2004)
Clinical Genetics
, vol.65
, Issue.5
, pp. 358-367
-
-
Nisselle, A.E.1
Delatycki, M.B.2
Collins, V.3
Metcalfe, S.4
Aitken, M.A.5
Du Sart, D.6
Halliday, J.7
Macciocca, I.8
Wakefield, A.9
Hill, V.10
Gason, A.11
Warner, B.12
Calabro, V.13
Williamson, R.14
Allen, K.J.15
-
24
-
-
0141794515
-
Patient compliance with phlebotomy therapy for iron overload associated with hemochromatosis
-
DOI 10.1111/j.1572-0241.2003.07292.x
-
Hicken BL, Tucker DC, Barton JC (2003) Patient compliance with phlebotomy therapy for iron overload associated with hemochromatosis. Am J Gastroenterol 98:2072-2077 (Pubitemid 37185808)
-
(2003)
American Journal of Gastroenterology
, vol.98
, Issue.9
, pp. 2072-2077
-
-
Hicken, B.L.1
Tucker, D.C.2
Barton, J.C.3
-
26
-
-
44049098205
-
The half-life of truth: What are appropriate time horizons for research decisions?
-
DOI 10.1177/0272989X07312724
-
Philips Z, Claxton K, Palmer S (2008) The half-life of the truth. Appropriate time horizons for research decisions? Med Decis Making 28(3):287-299 (Pubitemid 351713302)
-
(2008)
Medical Decision Making
, vol.28
, Issue.3
, pp. 287-299
-
-
Philips, Z.1
Claxton, K.2
Palmer, S.3
-
27
-
-
2442717630
-
Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis
-
DOI 10.1002/hec.864
-
Devlin N, Parkin D (2004) Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis. Health Econ 13:437-452 (Pubitemid 38660393)
-
(2004)
Health Economics
, vol.13
, Issue.5
, pp. 437-452
-
-
Devlin, N.1
Parkin, D.2
-
29
-
-
0010178771
-
Are pharmaceuticals cost-effective? A review of the evidence
-
Neumann PJ, Sandberg EA, Bell CM et al (2000) Are pharmaceuticals cost-effective? A review of the evidence. Health Aff (Millwood) 19:92-109
-
(2000)
Health Aff (Millwood)
, vol.19
, pp. 92-109
-
-
Neumann, P.J.1
Sandberg, E.A.2
Bell, C.M.3
-
30
-
-
41149171625
-
What does the value of modern medicine say about the $50, 000 per quality-adjusted life-year decision rule?
-
Braithwaite RS, Meltzer DO, King JT Jr et al (2008) What does the value of modern medicine say about the $50, 000 per quality-adjusted life-year decision rule? Med Care 46:349-356
-
(2008)
Med Care
, vol.46
, pp. 349-356
-
-
Braithwaite, R.S.1
Meltzer, D.O.2
King Jr., J.T.3
-
31
-
-
46949100710
-
Assessing cost-effectiveness in healthcare: History of the $50,000 per QALY threshold
-
DOI 10.1586/14737167.8.2.165
-
Grosse SD (2008) Assessing cost-effectiveness in healthcare: history of the $50, 000 per QALY threshold. Expert Rev Pharmacoecon Outcomes Res 8:165-178 (Pubitemid 351959547)
-
(2008)
Expert Review of Pharmacoeconomics and Outcomes Research
, vol.8
, Issue.2
, pp. 165-178
-
-
Grosse, S.D.1
-
32
-
-
41149134764
-
How much areamericans willing to pay for a quality-adjusted life year?
-
Weinstein MC (2008) How much areamericans willing to pay for a quality-adjusted life year? Med Care 46:343-345
-
(2008)
Med Care
, vol.46
, pp. 343-345
-
-
Weinstein, M.C.1
-
33
-
-
77951080958
-
The efficiency frontier approach to economic evaluation of health-care interventions
-
Caro JJ, Nord E, Siebert U et al (2010) The efficiency frontier approach to economic evaluation of health-care interventions. Health Econ 19:1117-1127
-
(2010)
Health Econ
, vol.19
, pp. 1117-1127
-
-
Caro, J.J.1
Nord, E.2
Siebert, U.3
-
34
-
-
77957332188
-
Sins of omission and obfuscation: IQWIG's guidelines on economic evaluation methods
-
Sculpher M, Claxton K (2010) Sins of omission and obfuscation: IQWIG's guidelines on economic evaluation methods. Health Econ 19:1132-1136
-
(2010)
Health Econ
, vol.19
, pp. 1132-1136
-
-
Sculpher, M.1
Claxton, K.2
-
35
-
-
36849005885
-
Costs and cost-effectiveness of a low-intensity patient-directed intervention to promote colorectal cancer screening
-
DOI 10.1200/JCO.2007.13.4098
-
Shankaran V, McKoy JM, Dandade N et al (2007) Costs and cost-effectiveness of a low-intensity patient-directed intervention to promote colorectal cancer screening. J Clin Oncol 25:5248-5253 (Pubitemid 350232257)
-
(2007)
Journal of Clinical Oncology
, vol.25
, Issue.33
, pp. 5248-5253
-
-
Shankaran, V.1
McKoy, J.M.2
Dandade, N.3
Nonzee, N.4
Tigue, C.A.5
Bennett, C.L.6
Denberg, T.D.7
-
36
-
-
77952886612
-
Cost-effectiveness of patient mailings to promote colorectal cancer screening
-
Sequist TD, Franz C, Ayanian JZ (2010) Cost-effectiveness of patient mailings to promote colorectal cancer screening. Med Care 48:553-557
-
(2010)
Med Care
, vol.48
, pp. 553-557
-
-
Sequist, T.D.1
Franz, C.2
Ayanian, J.Z.3
-
37
-
-
3042677239
-
Cost-effectiveness of an intervention to increase cancer screening in primary care settings
-
DOI 10.1016/j.ypmed.2004.03.021, PII S009174350400180X
-
Chirikos TN, Christman LK, Hunter S, Roetzheim RG (2004) Cost-effectiveness of an intervention to increase cancer screening in primary care settings. Prev Med 39:230-238 (Pubitemid 38834012)
-
(2004)
Preventive Medicine
, vol.39
, Issue.2
, pp. 230-238
-
-
Chirikos, T.N.1
Christman, L.K.2
Hunter, S.3
Roetzheim, R.G.4
|